Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,OR[95%CI],P_value
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,15792,137,3.22 [2.24-4.61],2.2966343798355319e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAMTSL2,ADAMTS-like protein 2,16282,139,4.06 [2.79-5.91],2.485654817422917e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADGRG1,Adhesion G-protein coupled receptor G1,18490,159,1.52 [1.34-1.74],3.0437801280042975e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANGPT2,Angiopoietin-2,18723,163,2.99 [2.20-4.07],3.3861203927956805e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AREG,Amphiregulin,18490,159,2.72 [2.13-3.48],8.907941857783628e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C7,Complement component C7,15880,135,4.83 [3.17-7.36],2.0392831078931762e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL21,C-C motif chemokine 21,18660,162,2.12 [1.74-2.58],1.3649521980274196e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD27,CD27 antigen,18648,157,2.38 [1.83-3.11],1.3965714884875679e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,16196,139,0.44 [0.37-0.54],4.128845036283206e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHI3L1,Chitinase-3-like protein 1,18206,159,1.60 [1.39-1.84],2.5399732875736817e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC3B,Tetranectin,15917,134,0.12 [0.06-0.23],6.32696142715129e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNDP1,Beta-Ala-His dipeptidase,18671,161,0.46 [0.37-0.59],1.8717468343870432e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL4A1,Collagen alpha-1(IV) chain,18584,161,2.72 [2.01-3.68],8.107878217967344e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL6A3,Collagen alpha-3(VI) chain,18801,163,2.52 [1.89-3.36],2.8526484293083885e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSF1,Macrophage colony-stimulating factor 1,18660,162,4.17 [2.72-6.40],5.2760296100284996e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EDA2R,Tumor necrosis factor receptor superfamily member 27,18723,163,2.57 [1.95-3.38],1.8728077972749758e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPHA2,Ephrin type-A receptor 2,17924,155,2.76 [2.00-3.81],8.177473247338147e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF21,Fibroblast growth factor 21,18693,163,1.43 [1.29-1.59],2.9373665740926716e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FSTL3,Follistatin-related protein 3,18548,161,3.52 [2.52-4.91],1.592605708248617e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,18723,162,2.54 [1.92-3.35],6.268745448653901e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GDF15,Growth/differentiation factor 15,18801,163,2.49 [2.01-3.08],4.751151815452815e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HAVCR1,Hepatitis A virus cellular receptor 1,18690,162,2.03 [1.72-2.41],2.728521250228997e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HGF,Hepatocyte growth factor,18753,162,3.31 [2.45-4.48],8.493627710660283e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBP3,Insulin-like growth factor-binding protein 3,18671,161,0.29 [0.21-0.40],4.259189031723861e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBP7,Insulin-like growth factor-binding protein 7,18801,163,2.78 [2.09-3.72],3.613579270244429e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL19,Interleukin-19,18114,158,1.85 [1.59-2.15],2.7474417107974414e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL1RL2,Interleukin-1 receptor-like 2,18225,158,0.26 [0.19-0.37],5.3211782583201626e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL2RA,Interleukin-2 receptor subunit alpha,18417,160,2.50 [1.87-3.34],7.266908794885804e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL6,Interleukin-6,18490,159,1.67 [1.49-1.87],3.6310319321171137e-19
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK11,Kallikrein-11,18478,156,2.29 [1.76-2.98],6.62636014565334e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,18581,162,2.45 [1.86-3.24],2.7165404449945757e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGALS4,Galectin-4,18581,162,2.00 [1.60-2.49],7.14398369013708e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LTBR,Tumor necrosis factor receptor superfamily member 3,18499,162,3.38 [2.31-4.94],3.5400514902831973e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LY96,Lymphocyte antigen 96,18398,157,3.32 [2.44-4.52],2.3778490516124574e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MEP1B,Meprin A subunit beta,18584,161,0.68 [0.60-0.76],5.694511341259827e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MRC1,Macrophage mannose receptor 1,16290,140,4.45 [2.80-7.08],2.9298420257974715e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MZB1,Marginal zone B- and B1-cell-specific protein,18638,162,2.41 [1.93-3.01],1.1343298375483375e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NTproBNP,N-terminal prohormone of brain natriuretic peptide,18584,161,1.38 [1.25-1.53],4.3139961012720575e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OCLN,Occludin,16246,139,2.41 [1.85-3.14],7.325535243662782e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PGF,Placenta growth factor,18753,162,3.57 [2.40-5.32],3.963313657026141e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PI3,Elafin,18354,160,1.87 [1.55-2.26],4.903490179814422e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PIGR,Polymeric immunoglobulin receptor,18345,158,3.60 [2.59-5.02],3.441033240067675e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PILRA,Paired immunoglobulin-like type 2 receptor alpha,18585,160,2.82 [2.03-3.92],7.710349037579013e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLAUR,Urokinase plasminogen activator surface receptor,18464,162,5.45 [3.65-8.16],1.38519563507715e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRSS8,Prostasin,18503,162,2.84 [2.13-3.80],1.711398087304702e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REN,Renin,18584,161,1.53 [1.34-1.74],3.81817022878236e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNASET2,Ribonuclease T2,18734,162,3.81 [2.54-5.71],1.0811583143967448e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMOC2,SPARC-related modular calcium-binding protein 2,18660,162,2.54 [1.88-3.42],8.678081492641852e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPON2,Spondin-2,18496,160,3.03 [2.14-4.28],3.505746422293342e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIMP1,Metalloproteinase inhibitor 1,18389,158,3.32 [2.34-4.72],1.7396689715349543e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,18398,157,2.75 [2.03-3.73],7.852321554141656e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,18585,160,2.94 [2.08-4.16],9.57279034062578e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TTR,Transthyretin,16127,136,0.14 [0.08-0.25],1.3291893182387702e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VEGFB,Vascular endothelial growth factor B,15792,137,5.19 [3.08-8.74],5.897970529621354e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WFDC2,WAP four-disulfide core domain protein 2,17672,144,2.55 [2.00-3.26],4.160603543200688e-14
